Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
US8247408B2 · kind B2 · utility
5Cited by
1References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2006 |
| Grant date | Aug 21, 2012 |
| Priority date | — |
| Expiry date | Dec 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to Compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.